X-129908063-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The ENST00000394422.8(UTP14A):c.106G>T(p.Asp36Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.0000208 in 1,204,591 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000018 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 0.000021 ( 0 hom. 7 hem. )
Consequence
UTP14A
ENST00000394422.8 missense
ENST00000394422.8 missense
Scores
1
6
10
Clinical Significance
Conservation
PhyloP100: 3.94
Genes affected
UTP14A (HGNC:10665): (UTP14A small subunit processome component) This gene encodes a member of the uridine triphosphate 14 family. As an essential component of a large ribonucleoprotein complex bound to the U3 small nucleolar RNA, the encoded protein is involved in ribosome biogenesis and 18S rRNA synthesis. An autosomal retrotransposed copy of this X-linked gene exists on chromosome 13. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.35674357).
BS2
High Hemizygotes in GnomAdExome4 at 7 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UTP14A | NM_006649.4 | c.106G>T | p.Asp36Tyr | missense_variant | 3/15 | ENST00000394422.8 | NP_006640.2 | |
LOC105373335 | XR_007068332.1 | n.2250+404C>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UTP14A | ENST00000394422.8 | c.106G>T | p.Asp36Tyr | missense_variant | 3/15 | 1 | NM_006649.4 | ENSP00000377944 | P1 | |
ENST00000432062.1 | n.293+404C>A | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111598Hom.: 0 Cov.: 22 AF XY: 0.0000296 AC XY: 1AN XY: 33780
GnomAD3 genomes
AF:
AC:
2
AN:
111598
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33780
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000227 AC: 4AN: 176225Hom.: 0 AF XY: 0.0000328 AC XY: 2AN XY: 61055
GnomAD3 exomes
AF:
AC:
4
AN:
176225
Hom.:
AF XY:
AC XY:
2
AN XY:
61055
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000210 AC: 23AN: 1092993Hom.: 0 Cov.: 29 AF XY: 0.0000195 AC XY: 7AN XY: 358687
GnomAD4 exome
AF:
AC:
23
AN:
1092993
Hom.:
Cov.:
29
AF XY:
AC XY:
7
AN XY:
358687
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111598Hom.: 0 Cov.: 22 AF XY: 0.0000296 AC XY: 1AN XY: 33780
GnomAD4 genome
AF:
AC:
2
AN:
111598
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33780
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 02, 2022 | The c.106G>T (p.D36Y) alteration is located in exon 3 (coding exon 3) of the UTP14A gene. This alteration results from a G to T substitution at nucleotide position 106, causing the aspartic acid (D) at amino acid position 36 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M
MutationTaster
Benign
D;N;N
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
1.0
.;D
Vest4
MutPred
Gain of phosphorylation at D36 (P = 0.0054);Gain of phosphorylation at D36 (P = 0.0054);
MVP
MPC
1.1
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at